Barr Drops Suit Vs. FDA Over Allegra Marketing Exclusivity

Law360, New York (April 12, 2005, 12:00 AM EDT) -- Generic drug maker Barr Pharmaceuticals Inc. has dropped a lawsuit against the U.S. Food and Drug Administration over exclusive marketing rights to a generic version of Sanofi-Aventis’ allergy treatment Allegra.

In February, Barr sued the FDA in the U.S. District Court for the District of Columbia to challenge its decision to make the company share its 180-day marketing exclusivity.

Under its existing policies, the FDA awards marketing exclusivity based on each patent filed in the Orange book, which can result in multiple companies having to share...
To view the full article, register now.